Christopher Slavinsky
Formerly General Counsel & Head of Compliance Corstasis Therapeutics
Seminars
Thursday 6th August 2026
Roundtable Discussions: Embedding Legal Leadership to Accelerate Cross-Functional Execution
3:00 pm
Wednesday 5th August 2026
Navigating Market-Aligned Merger Strategy to Preserve Valuation, Deal Certainty & Board Confidence
4:30 pm
- Aligning board, executive leadership, and external advisors under compressed timelines and shifting market conditions
- Protecting valuation and negotiation leverage while managing regulatory scrutiny, disclosure complexity, and operational continuity
- Preserving strategic optionality by anticipating antitrust, pricing, and capital-market dynamics and clearly framing risk trade-offs for board decision-making
